Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 636,293 |
|
|||||
| News | - | ||||||
| Day High | 32.13 | Low High |
|||||
| Day Low | 30.91 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arvinas Inc | ARVN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.94 | -2.89% | 31.60 | 16:01:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 32.00 | 30.91 | 32.13 | 31.60 | 32.54 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,108 | 636,293 | $ 31.74 | $ 20,195,527 | - | 13.57 - 53.08 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:20:01 | formt | 2,200 | $ 31.60 | USD |
Arvinas (ARVN) Options Flow Summary
Arvinas Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.15B | 68.08M | - | 78.5M | -367.3M | -5.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arvinas News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 33.42 | 35.865 | 30.91 | 34.22 | 759,698 | -1.82 | -5.45% |
| 1 Month | 41.71 | 41.98 | 30.91 | 36.21 | 611,114 | -10.11 | -24.24% |
| 3 Months | 43.46 | 53.08 | 30.91 | 43.86 | 779,639 | -11.86 | -27.29% |
| 6 Months | 14.53 | 53.08 | 13.57 | 36.27 | 791,247 | 17.07 | 117.48% |
| 1 Year | 27.33 | 53.08 | 13.57 | 32.03 | 604,654 | 4.27 | 15.62% |
| 3 Years | 64.54 | 108.465 | 13.57 | 47.73 | 502,184 | -32.94 | -51.04% |
| 5 Years | 22.76 | 108.465 | 13.57 | 47.03 | 487,711 | 8.84 | 38.84% |
Arvinas Description
| Arvinas Inc is a United States-based private biopharmaceutical company focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. Its pipeline candidates include metastatic castration-resistant prostate cancer, metastatic ER-breast cancer, additional oncology indications, tauopathies, and other neurodegenerative diseases. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766. |
